Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Golding

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
British Journal of Clinical Pharmacology|March 10, 2018
The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive functionJohn F Golding, Keith A Wesnes, Brian R Leaker
Human Factors|April 20, 2021
The Visually Induced Motion Sickness Susceptibility Questionnaire (VIMSSQ): Estimating Individual Susceptibility to Motion Sickness-Like Symptoms When Using Visual DevicesBehrang Keshavarz, Brandy Murovec, Niroshica Mohanathas, et al.
American Journal of Medical Genetics. Part A|May 3, 2013
Sleep disturbance as part of the neurofibromatosis type 1 phenotype in adultsGuy D Leschziner, John F Golding, Rosalie E Ferner
Seminars in Neurology|September 24, 2013
Vertigo and dizziness from environmental motion: visual vertigo, motion sickness, and drivers' disorientationAdolfo M Bronstein, John F Golding, Michael A Gresty
Psychological Research|February 24, 2016
Embodied perspective-taking indicated by selective disruption from aberrant self motionMark R Gardner, Chloé Stent, Christine Mohr, et al.
Autonomic Neuroscience : Basic & Clinical|November 2, 2010
The effect of smoking nicotine tobacco versus smoking deprivation on motion sicknessJohn F Golding, Olena Prosyanikova, Maria Flynn, et al.
British Journal of Clinical Pharmacology|July 15, 2023
An assessment of the effects of neurokinin<sub>1</sub> receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug developmentPaul L R Andrews, John F Golding, Gareth J Sanger
Aviation, Space, and Environmental Medicine|September 25, 2003
Suppression of sickness by controlled breathing during mildly nauseogenic motionFleur D Yen Pik Sang, John F Golding, Michael A Gresty
Aerospace Medicine and Human Performance|October 21, 2024
Sensitization of Visually Induced Motion Sickness by Prior Provocative Physical MotionJohn F Golding, Daniel Alund, Michael A Gresty, et al.
American Journal of Medical Genetics. Part A|June 4, 2011
Neurofibromatosis 2: a novel risk factor for hypertension?Rachael E Hornigold, John F Golding, Robin E Ferner, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Clinical Pharmacology|March 10, 2018
The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive functionJohn F Golding, Keith A Wesnes, Brian R Leaker
Human Factors|April 20, 2021
The Visually Induced Motion Sickness Susceptibility Questionnaire (VIMSSQ): Estimating Individual Susceptibility to Motion Sickness-Like Symptoms When Using Visual DevicesBehrang Keshavarz, Brandy Murovec, Niroshica Mohanathas, et al.
American Journal of Medical Genetics. Part A|May 3, 2013
Sleep disturbance as part of the neurofibromatosis type 1 phenotype in adultsGuy D Leschziner, John F Golding, Rosalie E Ferner
Seminars in Neurology|September 24, 2013
Vertigo and dizziness from environmental motion: visual vertigo, motion sickness, and drivers' disorientationAdolfo M Bronstein, John F Golding, Michael A Gresty
Psychological Research|February 24, 2016
Embodied perspective-taking indicated by selective disruption from aberrant self motionMark R Gardner, Chloé Stent, Christine Mohr, et al.
Autonomic Neuroscience : Basic & Clinical|November 2, 2010
The effect of smoking nicotine tobacco versus smoking deprivation on motion sicknessJohn F Golding, Olena Prosyanikova, Maria Flynn, et al.
British Journal of Clinical Pharmacology|July 15, 2023
An assessment of the effects of neurokinin<sub>1</sub> receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug developmentPaul L R Andrews, John F Golding, Gareth J Sanger
Aviation, Space, and Environmental Medicine|September 25, 2003
Suppression of sickness by controlled breathing during mildly nauseogenic motionFleur D Yen Pik Sang, John F Golding, Michael A Gresty
Aerospace Medicine and Human Performance|October 21, 2024
Sensitization of Visually Induced Motion Sickness by Prior Provocative Physical MotionJohn F Golding, Daniel Alund, Michael A Gresty, et al.
American Journal of Medical Genetics. Part A|June 4, 2011
Neurofibromatosis 2: a novel risk factor for hypertension?Rachael E Hornigold, John F Golding, Robin E Ferner, et al.
Pageof 6